Collision skin lesions-results of a multicenter study of the International Dermoscopy Society (IDS) by Blum, Andreas et al.
Research  |  Dermatol Pract Concept 2017;7(4):12 51
DERMATOLOGY PRACTICAL & CONCEPTUAL
www.derm101.com
Collision skin lesions—results of a multicenter 
study of the International Dermoscopy Society (IDS)
Andreas Blum1, Graeme Siggs2, Ashfaq A. Marghoob3, Jürgen Kreusch4, Horacio Cabo5, 
Gabriella Campos-do-Carmo6, Ana Flávia Cavalcanti Shiraishi 7, Alexander Kienitz8, 
Cayetana Maldonado-Seral9, Paola Maltagliati-Holzner10, Zeljko P. Mijuskovic11, 
Andrea M. Yoshimura12, Elvira Moscarella13, Harold S. Rabinovitz14, Cristina Rodriguez-Garcia15, 
Sonia Rodríguez Saa16, Pietro Rubegni17, Francesco Savoia18, Olga Simionescu19, 
Pedro Zaballos Diego20, Rainer Hofmann-Wellenhof21
1 Public, Private and Teaching Practice of Dermatology, Konstanz, Germany
2 SunDoctors Skin Cancer Clinic, Glenunga, Adelaide, Australia
3 Department of Dermatology, Memorial Sloan Kettering Skin Cancer Center, New York, NY, USA
4 Public and Private Practice of Dermatology, Lübeck, Germany
5 Research Institut, University of Buenos Aires, Argentina
6 Gávea Medical Center, Rio de Janeiro, Brazil
7 Dermatology Service, Hospital e Maternidade Celso Pierro, PUCC, Campinas, Sao Paulo, Brazil
8 Public and Private Practice of Dermatology, Dingolfing, Germany
9 Department of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain
10 Public and Private Practice of Dermatology, Stuttgart, Germany
11 Department of Dermatology and Venereology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia
12 University of Campinas, Campinas, Brazil
13 Dermatology and Skin Cancer Unit, Arcispedale S. Maria Nuova, IRCCS, Reggio Emilia, Italy
14 University of Miami, Miller School of Medicine, Miami, FL, USA
15 Department of Dermatology, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
16 Department of Dermatology, Hospital Del Carmen, Mendoza, Argentina
17 Department of Clinical Medicine and Immunological Science, Dermatology Section, University of Siena, Siena, Italy
18 Unit of Dermatology, AUSL della Romagna, Lugo, Italy
19 1st Clinic of Dermatology, Carol Davila University of Medicine and Pharmacy, Colentina Hospital, Bucharest, Romania
20 Dermatology Department, Hospital de Sant Pau i Santa Tecla, Tarragona, Spain
21 Department of Dermatology, Medical University of Graz, Graz, Austria
Key words: collision skin lesions, dermoscopy, dermatoscopy
Citation: Blum A, Siggs G, Marghoob AA, Kreusch J, Cabo H, Campos-do-Carmo G, Cavalcanti Shiraishi AF, Kienitz A, Maldonado-Seral 
C, Maltagliati-Holzner P, Mijuskovic ZP, Yoshimura AM, Moscarella E, Rabinovitz H, Rodriguez-Garcia C, Rodriguez Saa S, Rubegni P, 
Savoia F, Simionescu O, Zaballos Diego P, Hofmann-Wellenhof R. Collision skin lesions—results of a multicenter study of the International 
Dermoscopy Society (IDS). Dermatol Pract Concept 2017;7(4):51-62. DOI: https://doi.org/10.5826/dpc.0704a12
Received: June 7, 2017; Accepted: August 20, 2017; Published: July 31, 2017
Copyright: ©2017 Blum et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: None.
Competing interests: The authors have no conflicts of interest to disclose.
All authors have contributed significantly to this publication.
Corresponding author: Andreas Blum, MD, MSc, DermPrevOncol, Public and Private Teaching Practice of Dermatology, Augustinerplatz 7, 
78462 Konstanz, Germany. Tel.+49 7531 64311; Fax. +49 7531 60054. Email: a.blum@derma.de
52 Research  |  Dermatol Pract Concept 2017;7(4):12
Methods
Patient Selection and Design
In this retrospective, observational study, patients’ data and 
dermoscopic images of histopathologically diagnosed CSLs 
were included from 21 pigmented lesion clinics in nine coun-
tries: Argentina (2 centers), Australia, Brazil (3), Germany 
(4), Italy (4), Romania, Serbia, Spain (3), and United States 
of America (2).
CSLs were collected from July through December 2012 
via an e-mail request sent to all IDS members. For each lesion, 
a patient data intake form, digital dermoscopic polarized 
and/or non-polarized and in-focus image(s) in JPEG format 
were requested. The CSLs had to fit within the field of view 
of the image to be included in the study. The following data 
variables were recorded for each lesion: gender, age, ana-
tomic site, and the histopathology report. CSLs of the nails 
and mucosa were excluded. Anatomic sites were classified 
into head and neck, upper extremities, trunk, and lower 
extremities. The micro-anatomical location of the skin was 
classified as epidermal or dermal. Based on this the different 
subpopulations of cells within the CSLs were subdivided into 
epidermal-epidermal, epidermal-dermal and dermal-dermal 
combination according to the histopathology reports.
All data and digital images were assigned unique identifi-
ers, anonymized, and sent via e-mail to the study coordinator 
(AB). The approval for this study was waived by the Ethics 
Committee of the Medical Council Baden-Wuerttemberg, 
Stuttgart, Germany.
Introduction
Human skin consists of several layers with different cell types. 
Any possible intrinsic or extrinsic stimulation can trigger 
any one of these cells to proliferate, which can lead to the 
development of various combinations of skin tumors, both 
benign and malignant (Table 1). The challenge for the patient 
and clinician is to correctly diagnose these lesions with the 
aim of excising early skin cancer and minimizing the biopsy 
or excision of benign lesions.
Derm(at)oscopy is a noninvasive tool that helps improve 
the clinician’s diagnostic sensitivity and specificity. Dermos-
copy is widely accepted and used for the diagnosis of primary 
and recurrent pigmented and non-pigmented lesions of the 
skin, nail apparatus, hair, acral skin and mucosal areas [1-7] 
with a high diagnostic accuracy [8-12].
While the dermoscopic features of single lesions have been 
well described (Table 1), the possibilities and causes of colli-
sion skin lesions (CSLs) remain to be characterized. A Med-
line search performed before starting this study revealed a few 
case reports [13-31], and a few dermoscopic observations of 
a collection of CSLs with 17 pigmented actinic keratoses [32] 
in 3/130 dermatofibromas (2.3%) [33] and in 9/412 basal cell 
carcinomas (BCCs) (2.2%) [34].
In an effort to accrue a larger number of cases of CSLs, 
the International Dermoscopy Society (IDS) launched this 
multicenter retrospective, observational study. The aim of the 
study was to characterize the dermoscopic features of CSLs, 
to determine the most common lesions that occur in CSLs and 
to analyze possible reasons.
Background: Collision lesions as two independent and unrelated skin tumors often manifest an atypi-
cal morphology.
Objective: To determine the combinations of collision skin lesions (CSLs).
Methods: Twenty-one pigmented lesion clinics in nine countries included 77 histopathologically prov-
en CSLs in this retrospective observational study.
Results: Seventy-seven CSLs from 75 patients (median age 59.8 years) were analyzed; 24.7% of CSLs 
were located on the head and neck area, 5.2% on the upper extremities, 48.1% on the trunk, and 
11.7% on the lower extremities; 40.3% revealed a melanocytic component (median age 54.7 years), 
followed by 45.5% with a basal cell carcinoma (BCC) (median age 62.4 years) and 11.7% with a 
seborrheic keratosis (median age 64.7 years). CSLs with a BCC component were more often found on 
the head and neck area compared to tumors with a melanocytic component (34.3% versus 16.1%). 
Lesions with a melanocytic component were more often detected on the trunk compared to lesions 
with a BCC (64.5% versus 37.1%). Patients with CSLs with epidermal-epidermal cell combination 
were older than patients with epidermal-dermal cell combination (63 versus 55.2 years), were more 
often male than female (63% versus 43.3%), more often had the lesion on the head and neck area 
(32.6% versus 13.3%), and less often on the upper (2.2 % versus 10%) or lower extremities (8.7% 
versus 16.6%).
Conclusions: CSLs consist of a heterogeneous group of lesions of varying cell types. They are associ-
ated with advancing age and cumulative UV-exposure. CSLs manifest a complex morphology making 
it challenging to diagnose correctly.
ABSTRACT
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remaining lesions comprised one solar lentigo in combination 
with an angioma (1.3%) and one clear cell acanthoma with a 
dermatofibroma (1.3%). Patients with CSLs in which a mela-
nocytic tumor occurred were younger compared to patients 
with CSLs with BCC and seborrheic keratoses (54.7 versus 
62.4 and 64.7 years). CSLs with melanocytic or basal cell 
carcinoma were more often observed in males than in females 
(64.5% and 65.7%) compared to lesions with seborrheic 
keratoses (33.3%). CSLs with BCC were more often found on 
the head and neck area compared to lesions with melanocytic 
parts (34.3% versus 16.1%). Finally, lesions with melanocytic 
parts were more often detected on the trunk compared to 
lesions with BCC (64.5% versus 37.1%) (Table 2).
Regarding the 31 CSLs with a melanocytic component, 
22 were nevi, one was a severe melanocytic dysplasia and 
eight were melanomas. With these 31 melanocytic lesions, 14 
seborrheic keratoses (Figure 2), seven angiomas (Figure 3), 
six BCCs, three dermatofibromas and one squamous cell 
carcinoma were found as part of the CSLs. The case of the 
severe melanocytic dysplasia was associated with an angioma 
(Figure 4). Four melanomas were associated with a seborrheic 
keratosis (Figure 5), three melanomas with a BCC (Figure 6) 
and one melanoma with a squamous cell carcinoma in situ.
With regard to the 35 CSLs with a BCC component, 18 
seborrheic keratoses (Figure 7), five angiomas (Figure 8), 
Classification of Dermoscopic Images
During the process of evaluating and recording the dermo-
scopic criteria present in each image the researchers were 
aware of the histopathology diagnosis [35].
Results
General Data
The study consisted of 77 CSLs from 27 females (35.1%) and 
43 males (55.8%); for seven patients (9.1%) the gender was 
not recorded. The mean age of the patients was 59.8 years 
(range from 24 to 88 years); for 10 patients (12.9%) the age 
was not provided. Regarding the anatomic site, 19 CSLs were 
located on the head and neck (24.7%), four on the upper 
extremities (5.2%), 37 on the trunk (48.1%), and nine on the 
lower extremities (11.7%); for eight lesions this data was not 
available (10.3%) (Table 2).
Various Combinations of CSLs
The 77 cases were subclassified as follows (Figure 1): in the 
first step the CSLs were analyzed for the presence of any 
melanocytic features (benign or malignant) (n= 31; 40.3%); 
in the second step, lesions were analyzed for any BCC features 
(n=35; 45.5%); in the third step the lesions were analyzed 
for features of a seborrheic keratosis (n= 9; 11.7%) and the 
TABLE 1. Skin lesions or tumors with their original cell types of the different skin layers 
(focused only on skin lesions detectable by dermoscopy)
Layer of the Skin Cell Type or Functional Structure Associated Proliferations/Neoplasms
Epidermis Keratinocytes Solar lentigo
Seborrheic keratosis
Actinic keratosis
Bowen’s disease
Keratoacanthoma
Squamous cell carcinoma
Basal cell layer (non-differentiated 
folliculo-sebaceous-apocrine germ)
Trichoblastoma
Basal cell carcinoma
Melanocytes Melanocytic nevus
Melanoma 
Merkel cells Merkel cell carcinoma
Dermis Blood capillaries Angioma
Melanocytes Melanocytic (dermal or blue) nevus
Melanoma
Fibroblasts Dermatofibroma
Dermatofibrosarcoma protuberans
Non-Langerhans cells/histiocytes Xanthogranuloma
Infundibulo-follicular-sebaceous unit Sebaceous hyperplasia, milia, cyst, pilomatrixoma, 
trichoepithelioma, adnexal (benign or malignant) 
tumor
Myocytes Kaposi sarcoma
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in 30 cases and the dermal-dermal combination in only one 
case (dermal nevus with an angioma, not listed in Table 3).
Patients with the epidermal-epidermal combination were 
older than patients with the epidermal-dermal combination 
(63 versus 55.2 years), were more likely to be male than 
female (63% versus 43.3%), and more often had the lesions 
on the head and neck area (32.6% versus 13.3%) and less 
often on the upper (2.2% versus 10%) and lower extremities 
(8.7% versus 16.6%).
Discussion
Any possible combination of benign and malignant collision 
skin lesions (CSLs) comprising melanocytic, epithelial, dermal 
five dermatofibromas (Figure 9), two actinic keratoses, two 
hyperplasias of sebaceous glands, one clear cell acanthoma 
(Figure 10), one keratoacanthoma and one solar lentigo were 
found.
The nine CSLs with a seborrheic keratosis component 
(and without a melanocytic or BCC component), two solar 
lentigines (Figure 11), four angiomas (Figure 12), one hyper-
plasia of sebaceous glands and two squamous cell carcinomas 
were found.
Referencing Table 1, the data were additionally classified 
based on the combination of cells within the CSLs as either 
epidermal cells only, epidermal and dermal cells, and dermal 
cells only (Table 3). The epidermal-epidermal combination 
was found in 46 cases, the epidermal-dermal combination 
TABLE 2. Overview of age, gender and anatomic site data for all CSLs (which include the single 
lesion of a solar lentigo with an angioma, a clear cell acanthoma with a dermatofibroma and six le-
sions with additional inflammations), lesions with a melanocytic part (Melanocytic), basal cell carci-
nomas (BCC), and seborrheic keratoses (Seb.-ker.).
All lesions 
(n=77)
Melanocytic 
(n=31)
BCC (n=35) Seb.-ker. (n=9)
Median age in years (range in years) 59.8 (24-88) 54.7 (24-86) 62.4 (24-88) 64.7 (48-81)
Male (%) 43 (55.8) 20 (64.5) 23 (65.7) 3 (33.3)
Female (%) 27 (35.1) 8 (25.8) 10 (28.6) 4 (44.4)
Missing data for gender (%) 7 (9.1) 3 (9.7) 2 (5.7) 2 (22.2)
Head and Neck (%) 19 (24.7) 5 (16.1) 12 (34.3) 2 (22.2)
Upper extremities (%) 4 (5.2) 1 (3.2) 2 (5.7) -
Trunk (%) 37 (48.1) 20 (64.5) 13 (37.1) 3 (33.3)
Lower Extremities (%) 9 (11.7) 1 (3.2) 6 (17.1) 2 (22.2)
Missing data for anatomic site (%) 8 (10.3) 4 (12.9) 2 (5.7) 2 (22.2)
Figure 1. Subdivision of the 77 CSLs according to any detectable melanocytic origin (n= 31, 
melanocytic) in the first step, followed by any present basal cell carcinoma (n=35, BCC) in 
the second step, and finally nine seborrheic keratosis (seb.-ker.), one solar lentigo (SL) with an 
angioma and one clear cell acanthoma (CCA) with a dermatofibroma detected. [Copyright: 
©2017 Blum et al.]
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Figure 2a. CSL of a melanocytic nevus and a seborrheic keratosis in 
a 48-year-old male. [Copyright: ©2017 Blum et al.]
Figure 2b. Melanocytic nevus with regular brown network (A), 
and a seborrheic keratosis with comedo-like openings (B) and sulci/
crypts (C). [Copyright: ©2017 Blum et al.]
Figure 3a. CSL of a dermal nevus and an angioma in a 41-year-old 
female on her trunk. [Copyright: ©2017 Blum et al.]
Figure 3b. Dermal nevus with distinct brown globules (A), and an 
angioma with red lacunas (B). [Copyright: ©2017 Blum et al.]
Figure 4a. CSL of a severe melanocytic dysplasia and an angioma 
(unknown age, gender or area of lesion). [Copyright: ©2017 Blum 
et al.]
Figure 4b. Severe melanocytic dysplasia with asymmetrical radial 
streaks (A) and an angioma with red lacunas (B). [Copyright: ©2017 
Blum et al.
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Figure 5a. CSL of an invasive melanoma and a seborrheic keratosis 
in a 62-year-old male on his belly. [Copyright: ©2017 Blum et al.]
Figure 5b. Invasive melanoma with a brown-to-black homogenous 
symmetric pigmented single blotch (A) with distinct radial asymmet-
ric streaming (B), and a seborrheic keratosis with sulci/crypts in early 
(C) and advanced stages (D). [Copyright: ©2017 Blum et al.]
Figure 6a. CSL of a lentigo maligna and a basal cell carcinoma of 
a male at his face (unknown age). [Copyright: ©2017 Blum et al.]
Figure 6b. Lentigo maligna with pigmented follicles (A) and de-
stroyed follicle with patchy pigmentation (B), and a basal cell carci-
noma with arborizing vessels (C) and pigmented blue-grayish glob-
ules (D). [Copyright: ©2017 Blum et al.]
Figure 7a. CSL of a basal cell carcinoma and a seborrheic keratosis 
in a 65-year-old male on his arm. [Copyright: ©2017 Blum et al.]
Figure 7b. Basal cell carcinoma with ovoid blue-gray nests (A) and 
a seborrheic keratosis with brown fat-fingers (B), pseudo horn cysts 
(C) and sulci/crypts (D). [Copyright: ©2017 Blum et al.]
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Figure 8a. CSL of a basal cell carcinoma and an angioma in a 
67-year-old male on his back. [Copyright: ©2017 Blum et al.]
Figure 8b. Basal cell carcinoma with arborizing vessels (A) and one 
pigmented blue-grayish globule (B) and an angioma with red glob-
ules/lacunas (C). [Copyright: ©2017 Blum et al.]
Figure 9a. CSL of a basal cell carcinoma and a dermatofibroma in a 
40-year-old female on her arm [39]. [Copyright: ©2017 Blum et al.]
Figure 9b. Basal cell carcinoma with arborizing vessels (A) and a 
dermatofibroma with a central white patch and shiny white lines 
(B) and post-inflammatory peripheral hyperpigmentation (C) [39]. 
[Copyright: ©2017 Blum et al.]
Figure 10a. CSL of a basal cell carcinoma, a clear cell acanthoma 
and a seborrheic keratosis (unknown age, gender and area of lesion). 
[Copyright: ©2017 Blum et al.]
Figure 10b. Basal cell carcinoma with arborizing vessels (A) and 
pigmented blue-grayish globules (B), a clear cell acanthoma with 
dotted vessels in a line (C) and a seborrheic keratosis with brown 
fingerprint-like structures (D). [Copyright: ©2017 Blum et al.]
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or adnexal cells can occur in human skin [13-34,36-43]. Both 
intrinsic and extrinsic factors contribute to the likelihood of 
having two unrelated skin lesions occurring adjacent and 
contiguous with each other [44].
Age is an intrinsic factor, and although skin lesions are 
not found in abundance during youth or adolescence, when 
present, most of the lesions are melanocytic nevi. During 
adulthood more skin lesions from different cell types occur 
from epithelial more than melanocytic cells [45,46]. In this 
retrospective observational study, CSLs with a melanocytic 
component were found more often in patients younger than 
60 years of age. This can be explained by the fact that there 
is a progressive reduction of nevi with advancing age [47]. 
In contrast, in the groups of CSLs with BCC and seborrheic 
keratosis components, the median age was older than 60 
years. Once again, this can be explained by the fact that BCCs 
and seborrheic keratoses are more prevalent the older we 
get. Interestingly, in our image database we found melano-
cytic lesions with one squamous cell carcinoma and six with 
BCCs, which contradicts the observation of the literature 
and our study about the age distribution and the origin of 
melanocytic and epithelial skin lesions. This confirms again 
that probabilities are observed, but exceptions are always 
possible [13-34,36-43].
Skin type is also a known intrinsic factor. In Fitzpatrick 
skin types I and II, more epithelial skin lesions can occur dur-
Figure 11a. CSL of a seborrheic keratosis and a solar lentigo in an 
81-year-old male on his trunk. [Copyright: ©2017 Blum et al.]
Figure 11b. Seborrheic keratosis with comedo-like openings (A) 
and initial sulci/crypts (B) and a solar lentigo with brown homog-
enous (C) and more prominent network (D). [Copyright: ©2017 
Blum et al.]
Figure 12a. CSL of a seborrheic keratosis, an angioma and a so-
lar lentigo in a 67-year-old female on her belly. [Copyright: ©2017 
Blum et al.]
Figure 12b. Seborrheic keratosis with initial sulci/crypts (A) and 
comedo-like opening (B), an angioma with red lacunas (C) and a 
solar lentigo with brown homogenous network (D). [Copyright: 
©2017 Blum et al.]
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the observer from placing so much emphasis on dermoscopi-
cally prominent features within a CSL that the clinician stops 
searching for potentially subtler features that may be present 
and would assist in detecting skin cancer [51]. A good rule 
to follow is to evaluate, especially in benign lesions, all four 
quadrants of a lesion and to ensure that there are no signs of 
malignancy in any quadrant [50,52]. In complex dermoscopic 
images the switch between polarized and non-polarized light 
may be helpful as well [53,54].
This study has several limitations. (1) CSLs were only 
classified dermoscopically according to the histopathology 
reports given to the study coordinator. A further project 
with the collected images of CSLs should be the evaluation 
of diagnostic accuracy with a higher number of dermosco-
pists blinded to the histopathological result. (2) The specific 
diagnosis of the melanocytic nevi was rarely given (e.g., len-
tiginous or compound or dermal nevus), which could have 
influenced the analysis of the level of cell layers.
In conclusion, CSLs are found increasingly in the aging 
population with higher accumulative lifetime UV exposure 
(Figure 13). Many of these lesions will manifest a complex 
clinical morphology, including when the CSL consists of two 
benign lesions, leading, at times, to unnecessary biopsies and 
excisions. Dermoscopy may assist in correctly identifying the 
benign components of the CSLs that are composed of two 
or even more benign entities. However, dermoscopy can also 
lead to anchoring errors, resulting in the missed opportunity 
to biopsy a CSL that is composed of a benign and malignant 
entity. Awareness of this pitfall should help the observer in 
avoiding it. Reflectance confocal microscopy could be a new 
additional and helpful diagnostic tool for these CSLs [26,55-
57]. However, uncertain or non-classifiable lesions still need 
a complete excision for the final, correct diagnosis.
ing a lifetime compared to skin types III and IV [46,48]. This 
observation could not be investigated in this study because 
the data were not available.
The total lifetime dosage of UV radiation is considered 
an extrinsic reason for having CSLs [16,21,31,32,48]. UV-
induced proliferation of benign or malignant cell types can 
occur resulting in various combination of CSLs. Our study 
confirmed this observation: BCCs were more often found in 
sun-exposed areas (head and neck followed by the trunk) 
compared to melanocytic lesions (trunk followed by head and 
neck). Patients with CSLs with epidermal-epidermal tumor 
combinations were older than patients with the epidermal-
dermal tumoral combinations, more males than females had 
CSLs, and the CSLs were more often on the head and neck 
area—these three observations suggest that UV exposure is 
associated with CSLs and that the lifetime UV-exposure load 
may be greater in men then in women [45,48].
Viral infections in the elderly could also be an extrinsic 
factor for proliferation of epidermal skin cells, which could 
lead to Bowen’s disease or squamous cell carcinoma—but this 
hypothesis is still under discussion [49]. Any further investiga-
tion was not possible in this present study.
CSLs can pose diagnostic challenges. CSLs composed of 
two or more benign lesions can manifest a clinically irregular 
morphology leading to unnecessary biopsies or excisions. 
However, and more importantly, CSLs composed of benign 
and malignant lesions can sometimes be diagnosed as benign 
lesions due to anchoring bias (also known as confirmation 
bias) [50]. This occurs when the observer anchors their diag-
nosis on the benign features within a CSL and stops searching 
for features suggestive of malignancy. Such errors in visual 
perception can lead to the missed opportunity to biopsy or 
excise a skin cancer. Being aware of anchoring bias prevents 
TABLE 3. Overview of age, gender and anatomic site data according to the combination of epidermal-
epidermal cells and epidermal-dermal cells of the CSLs
Epidermal – 
epidermal cells (n=46)
Epidermal – 
dermal cells (n=30)
Median age in years (range in years) 63.0 (24-88) 55.2 (24-85)
Male (%) 29 (63.0) 13 (43.3)
Female (%) 13 (28.3) 13 (43.3)
Missing data for gender (%) 4 (8.7) 4 (13.4)
Head and Neck (%) 15 (32.6) 4 (13.3)
Upper extremities (%) 1 (2.2) 3 (10.0)
Trunk (%) 22 (47.8) 14 (46.7)
Lower Extremities (%) 4 (8.7) 5 (16.6)
Missing data for anatomic site (%) 4 (8.7) 4 (13.4)
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